A phase II study of temsirolimus (CCI-779) in patients with metastatic and/or locally advanced recurrent endometrial cancer previously treated with chemotherapy: NCIC CTG IND 160b Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Oza, AM
  • Elit, Laurie
  • Provencher, D
  • Biagi, JJ
  • Panasci, L
  • Sederias, J
  • Dancey, JE
  • Tsao, MS
  • Eisenhauer, EA

publication date

  • May 20, 2008